| DTMC |
NIDA-CPU-0005 |
Double-blind, placebo-controlled, safety and pharmacology study with 75 mg dosage of GBR 12909 in cocaine experienced African American Volunteers. |
Louis Cantilena, Jr., M.D, Ph.D. |
|
| DTMC |
NIDA-CPU-0004 |
Study of Interactions Between GBR 12909 and Cocaine |
Kathryn Cunningham, Ph.D., John Grabowski, Ph.D. |
|
| DTMC |
NIDA-CPU-0002 |
Double-Blind, Placebo-Controlled, Dose Escalating, Safety and Pharmacology Study With Three Dosages of GBR 12909 in Cocaine Experienced Volunteers |
Louis Cantilena, Jr., M.D, Ph.D. |
|
